Article
Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy.
Antiviral therapy - 1 Jan 2013
Huang Yi-Wen, Lin Shih-Chang, Wei Shu-Chen, Hu Jui-Ting, Chang Han-Yu, Huang Shih-Hung, Chen Ding-Shinn, Chen Pei-Jer, Hsu Ping-Ning, Yang Sien-Sing, Kao Jia-Horng
Abstract excerpt
BACKGROUND: Toll-like receptor (TLR)3 gene variants may correlate with clinical significance of chronic viral infections including HBV. We aimed to investigate the expression of TLR3 in peripheral blood mononuclear cells (PBMCs) and liver cells of chronic hepatitis B (CHB) patients and its response to pegylated interferon or nucleoside analogue therapy. METHODS: We consecutively enrolled 127 CHB patients and 64...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
